Clinical Trials Sponsored by Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Total 16 results
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Completed
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Completed
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Unknown
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...CompletedEfficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive EsophagitisErosive Esophagitis (EE)China
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Active, not recruitingFunctional ConstipationChina
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Completed
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Completed
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...Completed
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...CompletedHelicobacter Pylori InfectionChina
-
Shandong Luoxin Pharmaceutical Group Stock Co.,...CompletedHealthy Subjects | Pharmacokinetics of 14C-labeled of LXI-15028China
-
Luye Pharma Group Ltd.Shandong Luye Pharmaceutical Co., Ltd.Completed
-
Shandong UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.Not yet recruitingCervical Cancer | Ovarian CancerChina
-
Shandong Cancer Hospital and InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownNon Small Cell Lung CancerChina
-
Qilu Hospital of Shandong UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownAnlotinib Combined With Docetaxel for Advanced Non-squamous Non-Small Cell Lung Cancer (ACDFNSNSCLC)Non Small Cell Lung Cancer
-
Shandong Cancer Hospital and InstituteChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownNon Small Cell Lung CancerChina
-
Wuhan Union Hospital, ChinaZhongshan Hospital Xiamen University; The Affiliated Hospital of Qingdao University and other collaboratorsRecruiting